InterVene Receives FDA 510(k) Clearance for Recana® Thrombectomy System
InterVene, Inc., has announced that its Recana® Thrombectomy Catheter System has received 510(k) clearance from the U.S. Food and Drug Administration (FDA).
The Recana system is the first fully integrated thrombectomy technology developed specifically to address venous in-stent restenosis and native vessel blockages.
It combines several components—such as a debulking catheter, introducer, collection sheaths, and nitinol capture baskets—into a single, streamlined platform.
This integration is designed to simplify complex venous interventions, eliminate the need for multiple devices, and enhance procedural speed and efficiency.
A key feature of the system is its stainless-steel helical coring element with a sharpened edge for removing tough venous obstructions, complemented by a spiral nose cone that helps navigate through blockages.
The nitinol baskets efficiently capture and extract thrombotic debris during the procedure.
Venous in-stent restenosis and chronic vessel occlusions can cause significant long-term complications and are challenging to treat.
The Recana system offers a single-session, minimally invasive solution designed to streamline workflow and improve patient outcomes.